← All trials
NCT06679582
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2024
- Primary completion
- Dec 31, 2028
- Completion date
- Mar 31, 2029
- First posted
- Nov 7, 2024
- Last posted
- Nov 11, 2024
- Enrollment
- 24
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sutro BiopharmaLead sponsor
- Sutro BiopharmaOfficial
- Innovative Therapies For Children with Cancer ConsortiumCollaborator
- National Cancer Institute (NCI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.